Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Acetaminophen 💬1件: Acetaminophen (Nalocet)4件: Acetaminophen; PARACETAMOL; Tylenol; Ultracet2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬15件: 3, 6, 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
2 Buprenorphine 💬1件: Buprenorphine (PMS-buprenorphine-naloxone)1件: Buprenorphine2件: OPRK1,
OPRM1 💬 		3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬2件: 46, 70 💬
3 Bupropion 💬1件: Bupropion (Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release)2件: Bupropion; Bupropion Hydrochloride2件: SLC6A2,
SLC6A3 💬 		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬5件: 8, 18, 21, 96, 171 💬
4 Cromoglicic acid 💬1件: Cromoglicic acid (Nalcrom)4件: Cromoglicate; Cromoglycate; Cromolyn; Cromolyn Sodium--3件: 2, 85, 98 💬
5 Nalbuphine 💬
(Nalbuphine (INN))		1件: Nalbuphine (Nalbuphinum)2件: Nalbuphine; NALBUPHINE HYDROCHLORIDE3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
6 Nalmefene 💬
(Nalmefene (USAN/INN))		1件: Nalmefene (Nalmefene)1件: Nalmefene3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
7 Naloxone 💬
(Naloxone (INN), DBL Naloxone (TN))		1件: Naloxone (Pentazocine and naloxone hydrochlorides)2件: Naloxone; NALOXONE HYDROCHLORIDE3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 6, 226 💬
8 Naltrexone 💬
(Naltrexone (USAN/INN))		1件: Naltrexone (Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release)2件: Naltrexone; Naltrexone Hydrochloride3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬12件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
9 Oxycodone 💬1件: Oxycodone (Nalocet)2件: OXYCODONE; OXYCODONE HYDROCHLORIDE3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬5件: 6, 13, 70, 226, 298 💬
10 Triamcinolone 💬1件: Triamcinolone (Naltrexone)4件: Kenalog; Naltrexone; Triamcinolone; Triamcinolone Acetonide1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬11件: 35, 46, 53, 56, 70, 90, 96, 107, 162, 226, 298 💬